[2019] To find out why the committee made the research recommendation on fetal monitoring, see rationale and impact. 6 Advice and follow-up at transfer to community care In women who have had hypertension during pregnancy, what interventions reduce the risk of a) recurrent hypertensive disorders of pregnancy, and b) subsequent cardiovascular To find out why the committee made the research recommendation on follow-up after hypertensive disorders of pregnancy, see rationale and impact. Other recommendations for research (from 2010 guideline) Haematological and biochemical monitoring in women with gestational hypertension What is the role of assessing haematological or biochemical parameters at diagnosis of gestational hypertension and during surveillance of gestational hypertension? [2010] Rationale and impact These sections briefly explain why the committee made the recommendations and how they might affect practice. They link to details of the evidence and a full description of the committee's discussion. Assessment of proteinuria Why the committee made the recommendations The committee were aware that there is often over-reliance on a proteinuria result in the diagnosis of pre-eclampsia, and agreed that healthcare professionals should use the results of a full clinical review, including severity of hypertension and other signs and symptoms, before making a diagnosis of pre-eclampsia. The committee amended the recommendation on automated dipstick tests from the 2010 guideline to emphasise that this should be used as a screening tool for proteinuria. The committee highlighted the importance of using automated dipstick analysis in secondary care rather than visual analysis, which they were aware from their experience has a higher error rate. Protein:creatinine ratio (PCR) and albumin:creatinine ratio (ACR) were both shown to have high specificity and high sensitivity at the chosen thresholds (30 mg/mmol and 8 mg/mmol respectively), and therefore either could be used depending on local availability. 